Ned Tijdschr Geneeskd. 2000 Jun 3;144(23):1124-9.
To present an overview of the main results of the nationwide breast cancer screening programme implemented in the Netherlands from 1990 to 1997 and providing a biennial mammography for all women aged 50-69 years.
Data on screening examinations were provided by the 9 regional screening organisations; data on interval cancers and on breast cancers in unscreened women were provided by the regional cancer registries after linkage of registry data with data on screened women. The results observed were compared with the expectations used in the cost effectiveness analysis before the start of the population screening.
Of almost 4 million women invited, 78.5% attended for screening. The screening resulted in 13.1 referrals, 9.2 biopsies and 6.1 breast cancers detected per 1,000 initially screened women, and in 6.9 referrals, 4.5 biopsies and 3.5 detected breast cancers per 1,000 subsequently screened women. All these parameters showed a clear variation at regional level. In the first 2 years after initial screens 0.96 interval cancers per 1,000 women-years were diagnosed (0.93 per 1,000 women-years after subsequent screens). Of all screen-detected cancers 76% were ductal carcinomas in situ (13%) or invasive cancers < or = 20 mm in size (63%); 26% of the invasive cancers were lymph node positive. This stage distribution was clearly more favourable than that of interval cancers and of the breast cancers diagnosed in unscreened women. The detection of breast cancer at subsequent screening was lower than expected and the staging of the carcinomas was less favourable than expected; the other results were largely in accordance with the expectations.
概述1990年至1997年在荷兰实施的全国乳腺癌筛查计划的主要结果,该计划为所有50至69岁的女性提供两年一次的乳房X光检查。
筛查检查数据由9个区域筛查组织提供;间隔期癌症和未筛查女性乳腺癌的数据由区域癌症登记处提供,是在将登记处数据与筛查女性数据进行关联之后。将观察到的结果与人群筛查开始前成本效益分析中使用的预期进行比较。
在近400万受邀女性中,78.5%参加了筛查。每1000名最初接受筛查的女性中,筛查导致13.1例转诊、9.2例活检和6.1例乳腺癌被检测出;每1000名随后接受筛查的女性中,筛查导致6.9例转诊、4.5例活检和3.5例乳腺癌被检测出。所有这些参数在区域层面都有明显差异。在首次筛查后的头两年,每1000妇女年诊断出0.96例间隔期癌症(后续筛查后每1000妇女年为0.93例)。在所有筛查发现的癌症中,76%为原位导管癌(13%)或大小≤20毫米的浸润性癌(63%);26%的浸润性癌有淋巴结转移。这个阶段分布明显比间隔期癌症和未筛查女性中诊断出的乳腺癌更有利。后续筛查中乳腺癌的检出率低于预期,癌症分期也比预期的差;其他结果在很大程度上与预期相符。